Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 4/20 | 0.35 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14466493 | 0.82 | MGLL (0.34) | MGLLPSMB8PSMB5 | |
| SCHEMBL12352876 | 0.80 | PSMB8 (0.31) | PSMB8PSMB5 | |
| SCHEMBL43576 | 0.80 | PSMB8 (0.35) | MGLLPSMB8PSMB5 | |
| SCHEMBL19733637 | 0.79 | MGLL (0.31) | MGLLPSMB8PSMB5 | |
| SCHEMBL21660208 | 0.79 | NOTUM (0.36) | MGLLPSMB8PSMB5 | |
| SCHEMBL19526014 | 0.78 | MGLL (0.32) | MGLL | |
| SCHEMBL31522720 | 0.78 | PSMB8 (0.34) | MGLLPSMB8PSMB5 | |
| SCHEMBL19526017 | 0.78 | SMN1; SMN2 (0.32) | PSMB8PSMB5 | |
| SCHEMBL12516531 | 0.78 | PSMB8 (0.33) | MGLLPSMB8PSMB5 | |
| SCHEMBL13496833 | 0.76 | MGLL (0.37) | MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150139901-A1 | Radioactive Rhodium Complexes, Preparation Methods and Uses Thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE (INSERM) (FR) | 2015-05-21 | — | — | US | disclosed |
| US-20150139901-A1 | Radioactive Rhodium Complexes, Preparation Methods and Uses Thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE (INSERM) (FR) | 2015-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150139901-A1 | Radioactive Rhodium Complexes, Preparation Methods and Uses Thereof | RAB35, MRPL21, MRPS35 | MGLL 2294/4885PSMB8 3199/4885PSMB5 1096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.